Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc in Non-R5-Tropic HIV-1
NCT00098748Phase 3Completed
- Sponsor
- ViiV Healthcare
- Start
- Nov 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Nov 2004; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00098748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098748.